Peginterferon alpha-2b

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC, Fuzhou General Hospital

Conditions

Chronic Hepatitis B Patients With a Normal ALT Level and Low ViremiaChronic Hepatitis C

Phase 1

Peginterferon Alpha-2b Therapy in Chronic Hepatitis Patients With Normal ALT Level and Low Viremia

Fuzhou General HospitalChronic Hepatitis B Patients With a Normal ALT Level and Low Viremia

Start: 2021-12-10End: 2023-12-10Target: 300Updated: 2022-01-24

Phase 3

Efficacy and Safety of Boceprevir in Combination With Peginterferon Alfa-2b Plus Ribavirin in Pediatric Subjects With Chronic Hepatitis C Genotype 1 (P08034)

WithdrawnNCT01590225

Merck Sharp & Dohme LLCChronic Hepatitis C

Start: 2013-01-28End: 2021-08-18Updated: 2021-01-29